Potassium

Potassium

SCHEMBL3500911

Cc1ccc(Cl)cc1OC(C)C(=O)O.[K]

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.74
HTR2A P28223 1/20 0.74
HTR2C P28335 1/20 0.74
HTR2B P41595 1/20 0.74
TDP1 Q9NUW8 1/20 0.54
PTGDR2 Q9Y5Y4 5/20 0.53
PTGDR Q13258 1/20 0.53
TRPM4 Q8TD43 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.47
ALOX12 P18054 2/20 0.47
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
KMT2A Q03164 1/20 0.46
HPGD P15428 2/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HSD17B10 Q99714 1/20 0.46
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1702623 0.98 TSHR (0.77) TSHRHTR2AHTR2CHTR2BTDP1
SCHEMBL984047 0.98 TSHR (0.77) TSHRHTR2AHTR2CHTR2BTDP1
SCHEMBL572352 0.98 TSHR (0.77) TSHRHTR2AHTR2CHTR2BTDP1
Mecoprop SCHEMBL29426474 0.85 TSHR (1.00) TSHRHTR2AHTR2CHTR2BTDP1
Mecoprop-P SCHEMBL572351 0.85 TSHR (1.00) TSHRHTR2AHTR2CHTR2BTDP1
Mecoprop-P SCHEMBL29817687 0.85 TSHR (1.00) TSHRHTR2AHTR2CHTR2BTDP1
Mecoprop SCHEMBL7762943 0.85 TSHR (1.00) TSHRHTR2AHTR2CHTR2BTDP1
Mecoprop SCHEMBL9068516 0.85 TSHR (1.00) TSHRHTR2AHTR2CHTR2BTDP1
Mecoprop SCHEMBL11349605 0.85 TSHR (1.00) TSHRHTR2AHTR2CHTR2BTDP1
Mecoprop SCHEMBL54983 0.85 TSHR (1.00) TSHRHTR2AHTR2CHTR2BTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160369237-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECH INC (US) 2016-12-22 US disclosed
US-20100184033-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY Lineage Cell Therapeutics, Inc. 2010-07-22 US disclosed
US-20080226601-A1 Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods UNIVERSITY OF ROCHESTER (US) 2008-09-18 US disclosed
EP-1903873-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS THE UNIVERSITY OF ROCHESTER (US) 2008-04-02 EP disclosed
US-20080070303-A1 Using myocardial and/or muscle progenitor cells as modeling tool in tissue engineering; regenerative medicine and organ replacement ADVANCED CELL TECHNOLOGY 2008-03-20 US disclosed
WO-2007062198-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECHNOLOGY, INC. (US) 2007-05-31 WO disclosed
WO-2006135602-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS UNIVERSITY OF ROCHESTER (US) 2006-12-21 WO disclosed